Lonquek (Lipegfilgrastim) for Stem Cell Mobilization of Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma and Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Lipegfilgrastim (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 23 Oct 2017 Last checked against ClinicalTrials.gov record.
- 16 Oct 2017 Status changed from not yet recruiting to recruiting.
- 10 Jun 2017 Biomarkers information updated